The Valley Desk

NCT05856760 · Interventional trial

A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Overall registry status Completed

Phase 2

Conditions Immunoglobulin A Nephropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov